Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.5 USD | -0.94% | -2.61% | +6.42% |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
22/05 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.42% | 16TCr | |
+38.69% | 73TCr | |
+33.12% | 60TCr | |
-4.49% | 36TCr | |
+20.24% | 33TCr | |
+2.12% | 28TCr | |
+15.82% | 24TCr | |
+7.98% | 21TCr | |
-5.32% | 21TCr | |
+0.01% | 12TCr |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Mizuho Securities Cuts Amgen's Price Target to $194 From $222, Citing 'Potential 2022 Headwinds,' Says 'Valuations Could Be Even Lower;' Neutral Rating Kept